Investor profile
Juxtapose
See how your deck fits this investor's thesis, stage, and ticket size.
Analyse your fitInvestment thesis
Juxtapose is a creation-oriented investment firm that builds and funds technology companies entirely from within the firm. Its investment process begins with rigorous, multi-year concept development leveraging capabilities in commercial and industry diligence, user and ethnographic research, product and business design, and capital markets experience. Every portfolio company is 100% proprietary. The firm targets multi-decade opportunities in large, complex, and historically technology-resistant industries—particularly healthcare and financial services—with the explicit goal of achieving venture-like returns with private equity-like risk. Rather than funding outside founders, Juxtapose originates all ideas internally and then partners each greenlit concept with a world-class, seasoned founding CEO (average 20+ years of professional experience) to launch and scale the business. The firm deliberately maintains a small, high-conviction portfolio, spawning only one to two new businesses per year, and remains a deeply active partner to each founding CEO and team throughout the company's lifecycle.
Notable quotes
“"The venture model wasn't built for all companies. We are maybe the opposite of a venture capital fund."”
“"Our goal is for every company to be an industry killer."”
“"Stoyan and his team have moved quickly but thoughtfully to build a solution which really moves the needle for dentists while preserving the value of human expertise."”
Recent investments
| Company | Round | Size | Date |
|---|---|---|---|
| Euphony | Series A | — | 2026-04-01 |
| Wisdom | Series A | $21m | 2025-08-20 |
| Lanai | Seed | $10m | 2025-01-23 |
| Earned Wealth | Growth | $200m | 2024-07-12 |
| Herself Health | Series A | $26m | 2023-07-17 |
| Dayforward | Series A | $25m | 2023-01-23 |
| Bluebird Kids Health | Seed | $32m | 2023-01-01 |
| Tend | Series B+ | — | 2020-01-01 |
| Orchard | Series B+ | — | 2018-01-01 |
| Care/of | Series A | $12m | 2017-01-01 |
Frequent co-investors
Fit check
Is Juxtapose a match for your startup?
Upload your deck and get an instant AI-powered fit analysis — see exactly how your startup aligns with this investor's thesis, stage focus, and ticket size.
Analyse your fit